Skip Navigation



Carcinogenesis Advance Access published online on August 14, 2003

Carcinogenesis, doi:10.1093/carcin/bgg143
© 2003 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
24/11/1827    most recent
bgg143v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shen, J.
Right arrow Articles by Fukushima, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, J.
Right arrow Articles by Fukushima, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

CARCINOGENESIS

Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats-association with oxidative DNA damage and enhanced cell proliferation

Jun Shen 1, Hideki Wanibuchi 1, Elsayed I. Salim 1, Min Wei 1, Anna Kinoshita 1, Kaoru Yoshida 2, Ginji Endo 2, and Shoji Fukushima 1*

1 Department of Pathology, Osaka City University Medical School, 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
2 Department of Preventive Medicine and Environment Health, Osaka City University Medical School, 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan

* Corresponding author. E-mail: fukuchan{at}med.osaka-cu.ac.jp.

Received 28 April 2003 ; revised 17 July 2003 ; accepted 4 August 2003

Abstract

Arsenic is a notorious environmental toxicant known to be carcinogenic for the skin, lung, urinary bladder in human beings. The carcinogenicity of trimethylarsine oxide (TMAO), one organic metabolite of inorganic arsenics in humans and experimental animals, was investigated here in male Fischer 344 rats in a two-year carcinogenicity test. TMAO was administered to a total of 129 male rats ad libitum at concentrations of 0 (Control), 50 or 200 ppm in the drinking water. In animals which died or were killed from the 87th week until the end of 104th week, incidences of hepatocellular adenomas were 14.3%, 23.8% and 35.6% in the 0, 50 and 200 ppm treated-groups, respectively; the multiplicities were 0.21, 0.33 and 0.53. Both were significantly increased in the 200 ppm-treated group. While a variety of other tumors developed in various organs, they were present in all groups, including the controls, and were histologically diagnosed as those known to occur spontaneously in F344 rats. To test the contribution of reactive oxygen species (ROS) to TMAO tumorigenicity in the liver, 8-hydroxydeoxyguanosine (8-OHdG) formation was assessed by high performance liquid chromatography. The 8-OHdG values for the 200 ppm TMAO group were significantly higher than those for the control group. Furthermore, as assessed by the proliferating cell nuclear antigen (PCNA) index, cell proliferation in the normally appearing parenchyma was elevated by the TMAO treatment. These results indicate that TMAO exerts liver tumorigenicity with possible mechanistic roles for oxidative DNA damage and enhanced cell proliferation.

arsenic, liver, tumorigenicity, trimethylarsine oxide, 8-hydroxydeoxyguanosine, cell proliferation
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
J. Liu and M. P. Waalkes
Liver is a Target of Arsenic Carcinogenesis
Toxicol. Sci., September 1, 2008; 105(1): 24 - 32.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-X. Liu, M. M. Davidson, X. Tang, W. F. Walker, M. Athar, V. Ivanov, and T. K. Hei
Mitochondrial Damage Mediates Genotoxicity of Arsenic in Mammalian Cells
Cancer Res., April 15, 2005; 65(8): 3236 - 3242.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.